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patients. This is associated with histologic improvement, including
reversal of severe ﬁbrosis.
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Background: Landless and ultra-poor inhabitants of the island
hars area of northern Bangladesh face severe food shortages exac-
rbated by ﬂooding and drought. Livestock management patterns
esult in exposure to pathogens from livestock waste, increasing
he risk of zoonotic and emerging infectious diseases (EIDs). Educa-
ion and employment opportunities are extremely limited, poverty
ates exceed90%, fewwomenare able to read, andmore than75%of
hildren in the region are below standard height and weight guide-
ines, primarily due to protein and energy insufﬁciency. We report
n a project that reduces the risk of EIDs by reducing human expo-
ure to zoonotic pathogens of animal origin and by increasing food
ecurity.
Methods:Wecollecteddata representinghumanandveterinary
ealth, economic, and agricultural production from 1500 villagers
n 300 households in Bogra, Jamalpur, and Sirajganj Districts of
orthern Bangladesh to determine the impact of increased vet-
rinary care of dairy cows, behaviour change to reduce exposure
f villagers to manure and other sources of zoonotic disease, and
mproved agricultural production to increase household income.
re- and post-intervention data were compared for signiﬁcant
hange.
Results: Changes contributing to signiﬁcant reduction of expo-
ure to EID hazards included: removal of livestock from one in
hree households; improved manure management in all villages;
mproved water and human waste management through use of
atrines in all villages; and increased access to human and veteri-
ary health services for most villages. Average household income
ncreased more than 100% resulting in higher household consump-
ion of purchased protein and energy sources. These results did
ot capture how villagers understand the concept of adaption to
omplex systems.
Conclusion: This research reﬂects ﬁve of the six pillars of eco-
ealth (transdisciplinarity, community participation, gender and
conomic equity, sustainability, and knowledge to action). Risk of
merging infectiousdisease inpoor villages canbe reduced through
hanges in household and village behaviour including removal
f livestock from households, increased agricultural production
ieldinghigherhousehold incomesdirected at improved food secu-
ity, and improved delivery of animal and human health services.
owever, future research needs to address resilience in a vulnera-
le ecosystem to capture understanding and response to complex
daptive systems.
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The aim in the treatment of chronic hepatitis B (CHB) is to pre-
vent the development of cirrhosis and its complications, and the
development of hepatocellular carcinoma (HCC), by suppressing
the viral replication to as low a level as possible on a permanent
basis. In the two REVEAL studies, even subjects with HBV DNA lev-
els <300 copies/mL had an incidence of 338.8 and 108 per 100,000
person-years for cirrhosis and or HCC, incidences which are by
no means negligible. It is therefore advisable that HBV replication
should be suppressed to below PCR detectability.
While HBsAg seroclearance/seroconversion comes as near a
“cure” for CHB as possible, it is only achievable in a minority of
patients ( 10%) with both nucleos(t)ide analogues and interferon
treatment. It is also genotype dependent. With nucleos(t)ides as
with interferon treatment, patients with genotypes B and C, the
common genotypes in Asia, are unlikely to achieve HBsAg sero-
clearance/seroconversion.
PegylatedInterferon (:There are2 long-term follow-up studies.
At year 5 in 85 HBeAg-positive patients, 57% had ALT normaliza-
tion, 31% had HBV DNA levels =10,000 copies/mL and only 13% had
HBV DNA levels =400 copies/mL. 60% had HBeAg seroconversion
and 2.4% had HBsAg seroconversion. At year 3 in 230 HBeAg-
negative patients, 31% had ALT normalization, 28% had HBV DNA
levels =10,000 copies/mL and only 18% had HBV DNA levels =400
copies/mL. 8% had HBsAg seroconversion.
Nucleos(t)ide Analogues: After 5 years of entecavir and
tenofovir, >90% of on-treatment patients had HBV DNA <3-400
copies/mL. In the tenofovir study, 348 of the original 641 patients
(54%) had a third liver biopsy at year 5. 96% had improvement of >1
grade or no change in the ﬁbrosis score. The cumulative probability
of resistance is 1.2% for entecavir at year 6 and 0% for tenofovir at
year 5.
Conclusions: On long-term follow-up, 13-18% of patients
treated with pegylated interferon ( had HBV DNA <300 copies/mL.
With entecavir and tenofovir, long-term treatment is effective in
continuing HBV DNA suppression to <3-400 copies/mL in >90% of
